{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:28:38Z","timestamp":1772504918646,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001637","name":"University of Dublin Trinity College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000704","name":"Royal Society of Chemistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejmech.2024.116692","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T23:13:57Z","timestamp":1721690037000},"page":"116692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Candida antarctica Lipase B mediated kinetic resolution: A sustainable method for chiral synthesis of antiproliferative \u03b2-lactams"],"prefix":"10.1016","volume":"276","author":[{"given":"Eavan C.","family":"McLoughlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Twamley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5660-4944","authenticated-orcid":false,"given":"Niamh M.","family":"O'Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2024.116692_bib1","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.7861\/fhj.2021-0071","article-title":"Carbovigilance: curtailing the global pharmaceutical carbon footprint","volume":"8","author":"Ray","year":"2021","journal-title":"Future Healthc J"},{"issue":"12","key":"10.1016\/j.ejmech.2024.116692_bib2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1377\/hlthaff.2020.01247","article-title":"Health care pollution and public health damage in the United States: an update","volume":"39","author":"Eckelman","year":"2020","journal-title":"Health Aff."},{"key":"10.1016\/j.ejmech.2024.116692_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.crgsc.2021.100174","article-title":"Green synthesis interventions of pharmaceutical industries for sustainable development","volume":"4","author":"Mishra","year":"2021","journal-title":"Current Res. Green Sustaina. Chem."},{"key":"10.1016\/j.ejmech.2024.116692_bib4","article-title":"Metrics of green chemistry: waste minimization","volume":"33","author":"Sheldon","year":"2022","journal-title":"Curr. Opin. Green Sustainable Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2024.116692_bib5","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1016\/j.bmcl.2006.08.087","article-title":"Novel imidazole-based combretastatin A-4 analogues: evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin","volume":"16","author":"Bellina","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116692_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112110","article-title":"Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents","volume":"190","author":"Hamze","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116692_bib7","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.3390\/molecules19067881","article-title":"Synthesis and cytotoxic activity of a new group of heterocyclic analogues of the combretastatins","volume":"19","author":"Lipeeva","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116692_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2018.01.052","article-title":"Synthesis and biological evaluation of 4,6-diphenyl-2-(1H-pyrrol-1-yl)nicotinonitrile analogues of crolibulin and combretastatin A-4","volume":"146","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2024.116692_bib9","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1021\/jm101115u","article-title":"Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents","volume":"53","author":"O'Boyle","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116692_bib10","first-page":"203","article-title":"Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs","volume":"15","author":"Pettit","year":"2000","journal-title":"Anti Cancer Drug Des."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116692_bib11","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm0205797","article-title":"Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-Combretastatin A-4","volume":"48","author":"Pettit","year":"2005","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116692_bib12","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1021\/jm00010a011","article-title":"Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6","volume":"38","author":"Pettit","year":"1995","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116692_bib13","first-page":"1829","article-title":"Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature","volume":"57","author":"Dark","year":"1997","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116692_bib14","first-page":"200","article-title":"Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study","volume":"34","author":"Lin","year":"1988","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116692_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01954881","article-title":"Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4","volume":"45","author":"Pettit","year":"1989","journal-title":"Experientia"},{"issue":"19","key":"10.1016\/j.ejmech.2024.116692_bib16","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1021\/acs.jmedchem.6b00463","article-title":"Blocking blood flow to solid tumors by destabilizing tubulin: an approach to targeting tumor growth","volume":"59","author":"P\u00e9rez-P\u00e9rez","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116692_bib17","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3390\/molecules25112560","article-title":"Combretastatins: an overview of structure, probable mechanisms of action and potential applications","volume":"25","author":"Karatoprak","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116692_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: a review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116692_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chempr.2016.12.012","article-title":"Understanding the binding of cis and trans isomers of combretastatin to tubulin","volume":"2","author":"Rozas","year":"2017","journal-title":"Chem"},{"issue":"13","key":"10.1016\/j.ejmech.2024.116692_bib20","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1039\/C4OB02606C","article-title":"Synthesis of phenstatin\/isocombretastatin\u2013chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers","volume":"13","author":"Kamal","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"39","key":"10.1016\/j.ejmech.2024.116692_bib21","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1016\/j.tetlet.2007.07.151","article-title":"A new synthesis of combretastatins A-4 and AVE-8062A","volume":"48","author":"Lara-Ochoa","year":"2007","journal-title":"Tetrahedron Lett."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116692_bib22","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/ph15091044","article-title":"Synthesis, characterisation and mechanism of action of anticancer 3-Fluoroazetidin-2-ones","volume":"15","author":"Malebari","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116692_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112050","article-title":"\u03b2-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells","volume":"189","author":"Malebari","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116692_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejmech.2017.02.049","article-title":"\u03b2-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells","volume":"130","author":"Malebari","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116692_bib25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/ph14111119","article-title":"Synthesis and antiproliferative evaluation of 3-Chloroazetidin-2-ones with antimitotic activity: heterocyclic bridged analogues of combretastatin A-4","volume":"14","author":"Malebari","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116692_bib26","article-title":"Application of 2D EXSY and qNMR spectroscopy for diastereomeric excess determination following chiral resolution of \u03b2-lactams","volume":"12","author":"McLoughlin","year":"2022","journal-title":"Chemistry Open"},{"key":"10.1016\/j.ejmech.2024.116692_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106877","article-title":"Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers","volume":"141","author":"McLoughlin","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116692_bib28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/op200097d","article-title":"Using the right green yardstick: why process mass intensity is used in the pharmaceutical industry to drive more sustainable processes","volume":"15","author":"Jimenez-Gonzalez","year":"2011","journal-title":"Org. Process Res. Dev."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116692_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1039\/B206169B","article-title":"Metrics to \u2018green\u2019 chemistry\u2014which are the best?","volume":"4","author":"Constable","year":"2002","journal-title":"Green Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116692_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1039\/b007875l","article-title":"Green chemistry measures for process research and development","volume":"3","author":"Constable","year":"2001","journal-title":"Green Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116692_bib31","doi-asserted-by":"crossref","DOI":"10.1021\/acsorginorgau.1c00049","article-title":"Mechanoenzymology in the kinetic resolution of \u03b2-blockers: propranolol as a case study","volume":"2","author":"Gamboa-Vel\u00e1zquez","year":"2022","journal-title":"ACS Organic Inorganic Au"},{"issue":"40","key":"10.1016\/j.ejmech.2024.116692_bib32","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1021\/ja990793t","article-title":"Kinetic resolution when the chiral auxiliary is not enantiomerically pure: normal and abnormal behavior","volume":"121","author":"Luukas","year":"1999","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116692_bib33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2174\/1385272819666150819190956","article-title":"Hydrolases in organic chemistry. Recent achievements in the synthesis of pharmaceuticals","volume":"20","author":"M\u00e9ndez-S\u00e1nchez","year":"2016","journal-title":"Curr. Org. Chem."},{"issue":"44","key":"10.1016\/j.ejmech.2024.116692_bib34","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1016\/j.tet.2018.09.029","article-title":"Mechanoenzymatic resolution of racemic chiral amines, a green technique for the synthesis of pharmaceutical building blocks","volume":"74","author":"P\u00e9rez-Venegas","year":"2018","journal-title":"Tetrahedron"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116692_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1367-5931(02)00297-1","article-title":"Lipases as practical biocatalysts","volume":"6","author":"Reetz","year":"2002","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116692_bib36","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1021\/jacs.5b01031","article-title":"Chemoenzymatic dynamic kinetic resolution: a powerful tool for the preparation of enantiomerically pure alcohols and amines","volume":"137","author":"Verho","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116692_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccr.2007.12.010","article-title":"Approaches based on enzyme mediated kinetic to dynamic kinetic resolutions: a versatile route for chiral intermediates","volume":"252","author":"Kamal","year":"2008","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116692_bib38","series-title":"IUPAC: Compendium of Chemical Terminology","author":"McNaught","year":"1997"},{"issue":"10","key":"10.1016\/j.ejmech.2024.116692_bib39","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/catal9100802","article-title":"Biocatalysis as useful tool in asymmetric synthesis: an assessment of recently granted patents (2014\u20132019)","volume":"9","author":"de Mar\u00eda","year":"2019","journal-title":"Catalysts"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116692_bib40","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/acs.chemrev.1c00574","article-title":"Shortening synthetic routes to small molecule active pharmaceutical ingredients employing biocatalytic methods","volume":"122","author":"Simi\u0107","year":"2022","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116692_bib41","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/adsc.201900424","article-title":"Biocatalysis: a pharma perspective","volume":"361","author":"Adams","year":"2019","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2024.116692_bib42","unstructured":"COMMUNICATION FROM THE COMMISSION, The European Green Deal. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:52019DC0640 (accessed 21-7-23)."},{"issue":"15","key":"10.1016\/j.ejmech.2024.116692_bib43","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1039\/c3cs35446f","article-title":"Immobilisation and application of lipases in organic media","volume":"42","author":"Adlercreutz","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116692_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1134\/S0003683814040024","article-title":"Lipases in catalytic reactions of organic chemistry","volume":"50","author":"Bezborodov","year":"2014","journal-title":"Appl. Biochem. Microbiol."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116692_bib45","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1039\/c003811c","article-title":"Hydrolases: catalytically promiscuous enzymes for non-conventional reactions in organic synthesis","volume":"39","author":"Busto","year":"2010","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116692_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12010-012-9669-9","article-title":"Unraveling the rationale behind organic solvent stability of lipases","volume":"167","author":"Chakravorty","year":"2012","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116692_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12934-020-01428-8","article-title":"Microbial lipases and their industrial applications: a comprehensive review","volume":"19","author":"Chandra","year":"2020","journal-title":"Microb. Cell Factories"},{"issue":"8","key":"10.1016\/j.ejmech.2024.116692_bib48","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1021\/ja00087a002","article-title":"A structural basis for the chiral preferences of lipases","volume":"116","author":"Cygler","year":"1994","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116692_bib49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11947-009-0202-2","article-title":"A review on microbial lipases production","volume":"3","author":"Treichel","year":"2010","journal-title":"Food Bioprocess Technol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116692_bib50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/op0200165","article-title":"Lipases from Candida Antarctica: unique biocatalysts from a unique origin","volume":"6","author":"Kirk","year":"2002","journal-title":"Org. Process Res. Dev."},{"issue":"34","key":"10.1016\/j.ejmech.2024.116692_bib51","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1002\/ejoc.202100712","article-title":"Effect of the substituent and amino group position on the lipase-catalyzed resolution of \u03b3-amino esters: a molecular docking study shedding light on Candida Antarctica lipase B enantioselectivity","volume":"2021","author":"Ortega-Rojas","year":"2021","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2024.116692_bib52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molcatb.2014.07.010","article-title":"Enantiopreference of Candida Antarctica lipase B toward carboxylic acids: substrate models and enantioselectivity thereof","volume":"127","author":"Tsai","year":"2016","journal-title":"J. Mol. Catal. B Enzym."},{"issue":"7\u20138","key":"10.1016\/j.ejmech.2024.116692_bib53","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/adsc.200505434","article-title":"A new route to enantiopure \u03b2-aryl-substituted \u03b2-amino acids and 4-aryl-substituted \u03b2-lactams through lipase-catalyzed enantioselective ring cleavage of \u03b2-lactams","volume":"348","author":"Forr\u00f3","year":"2006","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2024.116692_bib54","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.tetasy.2007.11.016","article-title":"Candida Antarctica lipase B-catalyzed ring opening of 4-arylalkyl-substituted \u03b2-lactams","volume":"18","author":"Tasn\u00e1di","year":"2007","journal-title":"Tetrahedron: Asymmetry"},{"key":"10.1016\/j.ejmech.2024.116692_bib55","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/ejoc.201403467","article-title":"Studies on N-activation for the lipase-catalyzed enantioselective preparation of \u03b2-amino esters from 4-Phenylazetidin-2-one","author":"Sundell","year":"2015","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2024.116692_bib56","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1002\/ejoc.201000262","article-title":"New enzymatic two step cascade reaction for the preparation of a key intermediate for the taxol Sid\u00d6 chain","volume":"16","author":"Forr\u00f3","year":"2010","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2024.116692_bib57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molcatb.2015.11.011","article-title":"Enantioselective hydrolysis of 3,4-disubstituted \u03b2-lactams. An efficient enzymatic method for the preparation of a key Taxol side-chain intermediate","volume":"123","author":"Galla","year":"2016","journal-title":"J. Mol. Catal. B Enzym."},{"issue":"46","key":"10.1016\/j.ejmech.2024.116692_bib58","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1016\/j.tet.2003.09.057","article-title":"Lipase-catalyzed resolution of 4-aryl-substituted \u03b2-lactams: effect of substitution on the 4-aryl ring","volume":"59","author":"Carr","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.116692_bib59","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.tetasy.2007.06.033","article-title":"Enantioselective acylation of alcohols with fluorinated \u03b2-phenyl-\u03b2-lactams in the presence of Burkholderia cepacia lipase","volume":"18","author":"Li","year":"2007","journal-title":"Tetrahedron: Asymmetry"},{"issue":"13","key":"10.1016\/j.ejmech.2024.116692_bib61","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.tetasy.2007.06.033","article-title":"Enantioselective acylation of alcohols with fluorinated \u03b2-phenyl-\u03b2-lactams in the presence of Burkholderia cepacia lipase","volume":"18","author":"Li","year":"2007","journal-title":"Tetrahedron: Asymmetry"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:49:27Z","timestamp":1730738967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424005725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":60,"alternative-id":["S0223523424005725"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116692","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candida antarctica Lipase B mediated kinetic resolution: A sustainable method for chiral synthesis of antiproliferative \u03b2-lactams","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116692"}}